Lakewood Asset Management’s Eli Lilly LLY Stock Holding History

Lakewood Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-189	Closed	-$203K	–	109
2025 Q4	$203K	Buy	+189	New	+$181K	0.12%	98
2025 Q1	–	Sell	-720	Closed	-$556K	–	112
2024 Q4	$556K	Sell	720 -10	-1%	-$8.28K	0.38%	66
2024 Q3	$646K	Buy	730 +1	+0.1%	+$899	0.44%	64
2024 Q2	$660K	Hold	729	–	–	0.46%	61
2024 Q1	$567K	Sell	729 -110	-13%	-$78.3K	0.39%	64
2023 Q4	$489K	Hold	839	–	–	0.38%	63
2023 Q3	$450K	Hold	839	–	–	0.37%	63
2023 Q2	$393K	Buy	839 +1	+0.1%	+$419	0.31%	75
2023 Q1	$288K	Sell	838 -14	-2%	-$4.72K	0.24%	85
2022 Q4	$312K	Buy	+852	New	+$302K	0.25%	79

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Lakewood Asset Management's LLY Position: Q1 2026 in Review

Lakewood Asset Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 189 shares — an estimated $203K sold.

Lakewood Asset Management first reported a position in LLY in Q4 2022 and held it in 10 quarters. The position peaked at $660K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Lakewood Asset Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
Lakewood Asset Management sold 189 Eli Lilly shares in Q1 2026, an estimated $203K.
Lakewood Asset Management first reported a position in Eli Lilly in Q4 2022 and held it in 10 quarters.
Lakewood Asset Management's Eli Lilly position peaked at $660K in Q2 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lakewood Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.